title: Weekly paclitaxel with intermittent imatinib mesylate (Gleevec): tolerance and activity in recurrent epithelial ovarian cancer.
authors.affiliation: New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA. safrat@bezeqint.net
authors.forename: Tamar
authors.initials: T
authors.lastname: Safra
authors.forename: Eleni
authors.initials: E
authors.lastname: Andreopoulou
authors.forename: Benjamin
authors.initials: B
authors.lastname: Levinson
authors.forename: Lucia
authors.initials: L
authors.lastname: Borgato
authors.forename: Bhavana
authors.initials: B
authors.lastname: Pothuri
authors.forename: Stephanie
authors.initials: S
authors.lastname: Blank
authors.forename: Amy
authors.initials: A
authors.lastname: Tiersten
authors.forename: Leslie
authors.initials: L
authors.lastname: Boyd
authors.forename: John
authors.initials: J
authors.lastname: Curtin
authors.forename: Franco
authors.initials: F
authors.lastname: Muggia